David Liang
3PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Mar 03, 2022
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance.David Liang, Maurizio Sessa
|Dec 18, 2020
A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine.Lanfranco Pellesi, Roberto De Icco, Hassan Youssef Alawie
Pageof 1